TFS CAPITAL LLC - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 91 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2017$836,000
-35.5%
90,854
-47.6%
0.27%
+13.9%
Q2 2016$1,296,000
+793.8%
173,312
+1443.2%
0.24%
+1387.5%
Q4 2015$145,000
-34.7%
11,231
-48.0%
0.02%
-27.3%
Q2 2015$222,000
+29.8%
21,604
+46.9%
0.02%
+37.5%
Q4 2014$171,000
-64.4%
14,703
-32.2%
0.02%
-61.9%
Q3 2014$480,00021,6830.04%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders